ArticleBiomedicines2022

Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling.

Cher-Rin Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.